Cuproptosis RNA Database

RNA Name	Mechanism of Action	Effect on Cancer	Cancer Type	Reference
USP2-AS1 lncRNA	Part of a prognostic 2-lncRNA signature (BCCuS) impacting copper-induced cell death pathways	Predicts breast cancer prognosis and immune dysfunction	Breast Cancer	PubMed Reference PMID: 36699089
NIFK-AS1 lncRNA	Works in conjunction with USP2-AS1 in the BCCuS signature	Predicts sensitivity to therapies and patient survival	Breast Cancer	PubMed Reference PMID: 36699089
C6orf99 lncRNA	Regulates DLD mRNA via miR-370-3p and miR-432-5p in the cuproptosis pathway	Associated with endocrine therapy resistance in ER+ BC	Breast Cancer	PubMed Reference PMID: 37143115
CARMN lncRNA	Involved in the PRNP/miRNA hsa-miR-192-5p and hsa-miR-215-5p/lncRNA CARMN ceRNA network	Regulates PRNP in cuproptosis in breast cancer	Breast Cancer	PubMed Reference PMID: 36980514
LINC01863 lncRNA	Impacts cell proliferation in BC, associated with drug sensitivity	Role in immune infiltration and therapeutic responses	Breast Cancer	PubMed Reference PMID: 38772805
AC104211.1 lncRNA	Similar role as LINC01863, influencing BC cell viability and sensitivity to therapies	Prognostic and therapeutic implications	Breast Cancer	PubMed Reference PMID: 38772805
miR-204-5p miRNA	Regulates the SLC31A1 expression, part of the LINC01614/miR-204-5p/SLC31A1 axis	Associated with immune infiltration and poor prognosis	Breast Cancer	PubMed Reference PMID: 37884650
miR-200c-3p miRNA	Regulates ZFPM2 and CFL2	Associated with TNBC prognosis and immune infiltration	Breast Cancer	PubMed Reference PMID: 38601669
miR-203a-3p miRNA	Target of cuproptosis-related genes (CRGs)	Potential therapeutic target for TNBC	Breast Cancer	PubMed Reference PMID: 38601669
miR-370-3p miRNA	Targets DLD mRNA	Associated with endocrine therapy resistance in ER+ breast cancer	Breast Cancer	PubMed Reference PMID: 37143115

Cuproptosis RNA Database

24 research entries found